What is the role of iFOBT in screening for colorectal cancer?

Por Ransohoff, David F
Publicado em 2007

Cultivating Cohort Studies for Observational Translational Research

Por Ransohoff, David F.
Publicado no Cancer Epidemiol Biomarkers Prev (2013)

Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making

Por Ransohoff, David F
Publicado no J Natl Cancer Inst (2020)

Sources of Bias in Specimens for Research About Molecular Markers for Cancer

Por Ransohoff, David F., Gourlay, Margaret L.
Publicado em 2010

Principles of Cancer Screening: Lessons from History and Study Design Issues

Por Croswell, Jennifer M., Ransohoff, David F., Kramer, Barnett S.
Publicado em 2010

Recommendations for Post-Polypectomy Surveillance in Community Practice

Por Ransohoff, David F., Yankaskas, Bonnie, Gizlice, Ziya, Gangarosa, Lisa
Publicado em 2011

How can polygenic inheritance be used in population screening for common diseases?

Por Khoury, Muin J., Janssens, A. Cecile J.W., Ransohoff, David F.
Publicado no Genet Med (2013)

TAILORING COLORECTAL CANCER SCREENING BY CONSIDERING RISK OF ADVANCED PROXIMAL NEOPLASIA

Por Imperiale, Thomas F., Glowinski, Elizabeth A., Lin-Cooper, Ching, Ransohoff, David F.
Publicado em 2012

Derivation and validation of a scoring system to stratify the risk of advanced colorectal neoplasia in asymptomatic adults

Por Imperiale, Thomas F., Monahan, Patrick O., Stump, Timothy E., Glowinski, Elizabeth A., Ransohoff, David F.
Publicado no Ann Intern Med (2015)

Assessment of serum proteomics to detect large colon adenomas

Por Ransohoff, David F., Martin, Christopher, Wiggins, Wesley S., Hitt, Ben A., Keku, Temitope O., Galanko, Joseph A., Sandler, Robert S.
Publicado em 2008

Implications of New Colorectal Cancer Screening Technologies for Primary Care Practice

Por Zauber, Ann G., Levin, Theodore R, Jaffe, C. Carl, Galen, Barbara A., Ransohoff, David F., Brown, Martin L.
Publicado no Med Care (2008)

Risk of Advanced Neoplasia Using the National Cancer Institute’s Colorectal Cancer Risk Assessment Tool

Por Imperiale, Thomas F, Yu, Menggang, Monahan, Patrick O, Stump, Timothy E, Tabbey, Rebeka, Glowinski, Elizabeth, Ransohoff, David F
Publicado no J Natl Cancer Inst (2016)

Improving Colorectal Cancer Screening in Primary Care Practice: Innovative Strategies and Future Directions

Por Klabunde, Carrie N., Lanier, David, Breslau, Erica S., Zapka, Jane G., Fletcher, Robert H., Ransohoff, David F., Winawer, Sidney J.
Publicado em 2007

International Variation in Screening Mammography Interpretations in Community-Based Programs

Por Elmore, Joann G., Nakano, Connie Y., Koepsell, Thomas D., Desnick, Laurel M., D’Orsi, Carl J., Ransohoff, David F.
Publicado em 2003

Bone-Density Testing Interval and Transition to Osteoporosis in Older Women

Por Gourlay, Margaret L., Fine, Jason P., Preisser, John S., May, Ryan C., Li, Chenxi, Lui, Li-Yung, Ransohoff, David F., Cauley, Jane A., Ensrud, Kristine E.
Publicado em 2012

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

Por Esserman, Laura J., Thompson, Ian M., Reid, Brian, Nelson, Peter, Ransohoff, David F., Welch, H. Gilbert, Hwang, Shelley, Berry, Donald A., Kinzler, Kenneth W., Black, William C., Bissell, Mina, Parnes, Howard, Srivastava, Sudhir
Publicado no Lancet Oncol (2014)

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

Por Church, Timothy Robert, Wandell, Michael, Lofton-Day, Catherine, Mongin, Steven J, Burger, Matthias, Payne, Shannon R, Castaños-Vélez, Esmeralda, Blumenstein, Brent A, Rösch, Thomas, Osborn, Neal, Snover, Dale, Day, Robert W, Ransohoff, David F
Publicado em 2014

The European Polyp Surveillance (EPoS) trials – Rationale, Design and Methodology

Por Jover, Rodrigo, Bretthauer, Michael, Dekker, Evelien, Holme, Øyvind, Kaminski, Michal F., Løberg, Magnus, Zauber, Ann G., Hernán, Miguel A., Lansdorp-Vogelaar, Iris, Sunde, Annike, McFadden, Eleanor, Castells, Antoni, Regula, Jaroslaw, Quintero, Enrique, Pellisé, Maria, Senore, Carlo, Kalager, Mette, Dinis-Ribeiro, Mario, Emilsson, Louise, Ransohoff, David F., Hoff, Geir, Adami, Hans-Olov
Publicado no Endoscopy (2016)

Leveraging Biospecimen Resources for Discovery or Validation of Markers for Early Cancer Detection

Por Schully, Sheri D., Carrick, Danielle M., Mechanic, Leah E., Srivastava, Sudhir, Anderson, Garnet L., Baron, John A., Berg, Christine D., Cullen, Jennifer, Diamandis, Eleftherios P., Doria-Rose, V. Paul, Goddard, Katrina A. B., Hankinson, Susan E., Kushi, Lawrence H., Larson, Eric B., McShane, Lisa M., Schilsky, Richard L., Shak, Steven, Skates, Steven J., Urban, Nicole, Kramer, Barnett S., Khoury, Muin J., Ransohoff, David F.
Publicado no J Natl Cancer Inst (2015)

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Por Zhu, Claire S., Pinsky, Paul F., Cramer, Daniel W., Ransohoff, David F., Hartge, Patricia, Pfeiffer, Ruth M., Urban, Nicole, Mor, Gil, Bast, Robert C., Moore, Lee E., Lokshin, Anna E., McIntosh, Martin W., Skates, Steven J., Vitonis, Allison, Zhang, Zhen, Ward, David C., Symanowski, James T., Lomakin, Aleksey, Fung, Eric T., Sluss, Patrick M., Scholler, Nathalie, Lu, Karen H., Marrangoni, Adele M., Patriotis, Christos, Srivastava, Sudhir, Buys, Saundra S., Berg, Christine D.
Publicado em 2011